Pharmaceutical composition for suppressing tmprss2 expression
AssigneesTokyo Institute of Technology, SBI Pharmaceuticals Co., Ltd.
InventorsShunichiro Ogura, Motowo Nakajima, Masahiro Ishizuka, Takuya Ishii, Hideo Imazato
Life of this patent
Estimating the term…
Abstract
The object of the present invention is to search for a compound that may suppress the expression of TMPRSS2 in a cell or tissue. The expression of TMPRSS2 in a cell or tissue is suppressed by 5-aminolevulinic acids.
Claims13
A pharmaceutical composition for suppressing the expression of type II transmembrane serine protease (TMPRSS2), comprising a compound shown by the following Formula (I):
- R1—NHCH2COCH2CH2COOR2 (I)
- wherein R1 represents a hydrogen atom or an acyl group, and R2 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aryl group, or an aralkyl group;
- or a salt or an ester thereof.
The pharmaceutical composition according to claim characterized in that R1 and R2 are hydrogen atoms.
(canceled)
A method for suppressing the expression of type II transmembrane serine protease (TMPRSS2), comprising a step of applying to a subject an effective amount of a compound shown by the following Formula (I):
- R1—NHCH2COCH2CH2COOR2 (I)
- wherein R1 represents a hydrogen atom or an acyl group, and R2 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aryl group, or an aralkyl group;
- or a salt or an ester thereof.
A kit for suppressing the expression of TMPRSS2, characterized in that it comprises a compound shown by the following Formula (I):
- wherein R1 represents a hydrogen atom or an acyl group, and R2 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aryl group, or an aralkyl group);
- or a pharmaceutically acceptable salt or ester thereof.
Dependencies are inferred from the claim text.